IP Verse

Amorphous Lercanidipine Hydrochloride - EP1856051

The patent EP1856051 was granted to Recordati Industria Chimica E Farmaceutica on Nov 13, 2019. The application was originally filed on Feb 24, 2006 under application number EP06723128A. The patent is currently recorded with a legal status of "Revoked".

EP1856051

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA
Application Number
EP06723128A
Filing Date
Feb 24, 2006
Status
Revoked
Oct 14, 2022
Grant Date
Nov 13, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELAug 12, 2020HAMM & WITTKOPPADMISSIBLE
HEUMANN PHARMA GENERICAAug 4, 2020ENGELHARDADMISSIBLE
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBJul 8, 2020BINDERADMISSIBLE
FRESENIUS KABI DEUTSCHLANDJul 1, 2020FRESENIUS KABI DEUTSCHLANDADMISSIBLE
SANDOZJun 8, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
ELKINGTON AND FIFEApr 6, 2020ELKINGTON AND FIFEADMISSIBLE
GLENMARK LIFE SCIENCESNov 13, 2019HGFADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS4705797
INTERNATIONAL-SEARCH-REPORTUS5912351
OPPOSITIONEP1432683
OPPOSITIONIN1593MUM2005
OPPOSITIONIN75MUM2006
OPPOSITIONUS4705797
OPPOSITIONUS5912351
OPPOSITIONUY29150
OPPOSITIONWO03014084
OPPOSITIONWO03014085
OPPOSITIONWO2006037650
OPPOSITIONWO2006089787
OPPOSITIONWO2007031865
OPPOSITIONWO2007054969
OPPOSITIONWO2008015248
OPPOSITIONWO9635668
OTHEREP0153016
OTHERUS4705797
OTHERWO03014084
OTHERWO03014085
OTHERWO9635668

Non-Patent Literature (NPL) Citations (40) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "2.8 Amorphous Powders", Richard A. Storey, JOHN WILEY & SONS, (20110000), XP055729762-
OPPOSITION- Anonymous, "ITWG GUIDELINE ON POWDER X-RAY DIFFRACTION (XRD) -GENERAL OVERVIEW", Nuclear Forensics International Technical Working Group, (20160000), pages 2pp, 1 - 4, XP055715110-
OPPOSITION- Anonymous, "ITWG GUIDELINE ON POWDER X-RAY DIFFRACTION (XRD) -GENERAL OVERVIEW", Nuclear Forensics International Technical Working Group,, (20160000), pages 2pp, 1 - 4, XP055715110-
OPPOSITION- Anonymous, "ITWG GUIDELINE ON POWDER X-RAY DIFFRACTION (XRD) -GENERAL OVERVIEW", Nuclear Forensics International Technical Working Group, (20160101), pages 2pp, 1 - 4, XP055715110-
OPPOSITION- Brian S. Furniss, Antony J. Hannaford, Peter W. G. Smith, Austin R. Tatchell, VOGEL'S TEXTBOOK OF Practical Organic Chemistry, Fifth Edition, England, Longman Scientific Technical, (19890000), pages 2pp, 197 - 199, 232-234, 1287-1297, XP055656678-
OPPOSITION- Brian S Furniss; Antony J Hannaford; Peter W G Smith; Austin R Tatchell, Vogel's Textbook of Practical Organic Chemistry, Fifth Edition, Longman Scientific Technical, England, (19890000), pages 197-199 , 232-234 and 1287 - 1297, XP055656678-
OPPOSITION- Brian S Furniss; Antony J Hannaford; Peter W G Smith; Austin R Tatchell, VOGEL'S TEXTBOOK OF Practical Organic Chemistry, Fifth Edition,, Longman Scientific Technical, England, (19890000), pages 2pp, 197 - 199, 232-234, 1287-1297, XP055656678-
OPPOSITION- Brian S. Furniss, Antony J. Hannaford, Peter W. G. Smith, Austin R. Tatchell, "VOGEL'S TEXTBOOK OF Practical Organic Chemistry, Fifth Edition /Passage/", VOGEL'S TEXTBOOK OF Practical Organic Chemistry, Fifth Edition, England, Longman Scientific Technical, (19890101), pages 2pp, 197 - 199, 232-234, 1287-1297, XP055656678-
OPPOSITION- "CHAPTER 8 - COLUMN AND THIN-LAYER LIQUID CHROMATOGRAPHY", G H Jeffery Et Al., VOGEL’s TEXTBOOK OF QUANTITATIVE CHEMICAL ANALYSIS FIFTH EDITION, (19890000), page 2PP, 216-229, 232 to 233, XP055715081-
OPPOSITION- "CHAPTER 8 - COLUMN AND THIN-LAYER LIQUID CHROMATOGRAPHY", Jeffery Et Al G H, Vogel's Textbook of Quantitative Chemical Analysis, (19890000), pages 216, 220 - 229 , 232, 233, XP055715081-
OPPOSITION- "Generation of polymorphd,Hydrates,Solvates, and amorphous solids", Harry G Brittain, Polymorphism in Pharmaceutical Solids, MARCEL DEKKER, (19990000), pages 183 - 202 and 208-219, XP055729764-
OPPOSITION- G H Jeffery Et Al.,, "CHAPTER 8 - COLUMN AND THIN-LAYER LIQUID CHROMATOGRAPHY", VOGEL’s TEXTBOOK OF QUANTITATIVE CHEMICAL ANALYSIS FIFTH EDITION, (19890101), pages 2PP, 216 - 233, XP055715081-
OPPOSITION- G H Jeffery, J Bassett, J Mendham, R C Denney, VOGEL'S TEXTBOOK OF QUANTITATIVE CHEMICAL ANALYSIS, Fifth Edition, England, Longman Scientific Technical, (19890000), pages 2pp, 216, 220 - 229, 232, 233, XP055656674-
OPPOSITION- GLENMARK LIFE SCIENCES LIMITED, Experimental Report-
OPPOSITION- "HANDBOOK OF PHARMACEUTICAL ANALYSIS BY HPLC /Passage/", Satinder Ahuja; Michael W Dong, HANDBOOK OF PHARMACEUTICAL ANALYSIS BY HPLC,, Elsevier Academic Press, (20050209), pages 2pp, 19-22, 43, 44, 123-127, 133, 134, 200-203, 212, 262, 274, 275, 370 - 377, XP055656652-
OPPOSITION- Ich Expert Working Group, "ICH HARMONISED TRIPARTITE GUIDELINE - Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A", INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE,, (19991006), pages 1 - 31, XP055268664-
OPPOSITION- Lloyd R Snyder Et Al, Practical HPLC Method Development Second Edition, Hoboken NJ, USA, John Wiley and Sons, Inc., (19970000), pages 2pp, 292-300, 616 - 642, XP055715094-
OPPOSITION- L. R. SNYDER et al., "Chapter 7 and 13", L. R. SNYDER et al., Snyder L. R., Joseph J. Kirkland, Joeseph L. Glajch, Practical HPLC Method Development, Hoboken NJ, USA, (19970000), pages 292-300 - 616-640, XP055721554-
OPPOSITION- L. R. Snyder, Joseph J. Kirkland, Joeseph L. Glajch, "Chapter 7 and 13", Practical HPLC Method Development, Hoboken NJ, USA, (19970101), pages 292 - 616-640, XP055721554-
OPPOSITION- L. YU, "Amorphous pharmaceutical solids: preparation, characterisation and stabilisation", Advanced Drug Delivery Reviews, (20010000), vol. 48, pages 27 - 42, XP055721630-
OPPOSITION- Manin C. Mcmaster, "HPLC A Practical User’s Guide /Passage/", HPLC A Practical User’s Guide, VCH Publishers, Inc., (19940101), pages 3PP, V - 150, XP055753995-
OPPOSITION- Manin C. McMaster, HPLC A Practical User’s Guide, VCH Publishers, Inc., (19940000), pages 3PP, V-XII, 3-13, 129 - 150, XP055753995-
OPPOSITION- M BAVIN, "Polymorphism in process Development", Chemistry & Industry, (19890821), pages 527 - 529, XP001180136-
OPPOSITION- M BAVIN, "Polymorphism in Process Development", Chemistry & Industry, (19890821), pages 527 - 529, XP001180136-
OPPOSITION- Micheal E Aulton, "Pharmaceutics - The Science of Dosage Form Design", (20020000), vol. 2nd Edit, page 26 and 239, XP055729763-
OPPOSITION- Ornaf Raphael M, Et Al, "Key concepts of HPLC in Pharmaceutical Analysis", Handbook of Pharmaceutical Analysis by HPLC, (20050101), XP055775510-
OPPOSITION- "Practical HPLC Method Development Second Edition /Passage/", R. SNYDER et al., Practical HPLC Method Development Second Edition, Hoboken NJ, USA, John Wiley and Sons, Inc.,, (19970000), page 2pp, 292-300, 616 to 642, XP055715094-
OPPOSITION- Rolf Hilfiker, "relevance of solid-state properties for pharmaceutical products", WILEY-VCH, WEINHEIM (DE), (20060821), vol. 1, pages 259 - 269 , 276-277 and 386, XP002525043-
OPPOSITION- R. PENNINI et al., "Synthesis and purification of lercanidipine HCl as reported in US4,705,797", ANALYTICAL REPORT #56, (20100916), pages 1 - 5-
OPPOSITION- R. Pennini, R. Dilemia, "Synthesis and purification of lercanidipine HC1 as reported in US 4,705,797", ANALYTICAL REPORT #56, (20100916), pages 1 - 5-
OPPOSITION- Satinder Ahuja; Michael W Dong, HANDBOOK OF PHARMACEUTICAL ANALYSIS BY HPLC, Elsevier Academic Press, (20050209), pages 19-22 , 43 , 44 , 123-127 , 133 , 134 , 200-203 , 212, 262, 274 , 275 , 370 - 377, XP055656652-
OPPOSITION- Satinder Ahuja, Michael W. Dong, HANDBOOK OF PHARMACEUTICAL ANALYSIS BY HPLC, Elsevier Academic Press, (20050209), pages 2pp, 19 - 22 , 43 , 44 , 123-127 , 133 , 134 , 200-203 , 212, 262, 274 , 275 , 370-377, XP055656652-
OPPOSITION- L. YU, "Amorphous pharmaceutical solids: preparation, characterisation and stabilisation", Advanced Drug Delivery Reviews, (20010000), pages 27 - 42, XP009065056
OPPOSITION- YU L, "AMORPHOUS PHARMACEUTICAL SOLIDS: PREPARATION, CHARACTERIZATION AND STABILIZATION", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL, (20010516), vol. 48, no. 01, doi:10.1016/S0169-409X(01)00098-9, ISSN 0169-409X, pages 27 - 42, XP009065056
OPPOSITION- B C HANCOCK et al., "Characteristics and Significance of the Amorphous State in Pharmaceutical Systems", Journal of Pharmaceutical Sciences, (19970000), doi:10.1021/js9601896, pages 1 - 12, XP000929450
OPPOSITION- B C HANCOCK et al., "Characteristics and Significance of the Amorphous State in Pharmaceutical Systems", Journal of Pharmaceutical Sciences, (19970112), pages 1 - 12, XP055274556
OPPOSITION- S BYRN et al., "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950700), vol. 12, no. 7, doi:10.1023/A:1016241927429, pages 945 - 954, XP055399407
OPPOSITION- Stephen Byrn; Pfeiffer Ralph; Ganey Michael; Hoiberg Charles; Poochikian Guirag, "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950700), vol. 12, no. 7, doi:10.1023/A:1016241927429, pages 945 - 954, XP055399407
OPPOSITION- B C HANCOCK et al., "Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures", Pharmaceutical Research, (19950600), vol. 12, no. 6, doi:10.1023/A:1016292416526, pages 799 - 806, XP002503243
OPPOSITION- HANCOCK B C; SHAMBLIN S L; ZOGRAFI G, "Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures", Pharmaceutical Research, (19950600), vol. 12, no. 6, doi:10.1023/A:1016292416526, pages 799 - 806, XP002503243

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents